The Effect of ERAS on Pancreaticoduodenectomy (v2.0)

NANot yet recruitingINTERVENTIONAL
Enrollment

334

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Periampullary CancerBorderline Malignancy Tumor
Interventions
OTHER

ERAS perioperative management

"* Epidural analgesia~* Fluid balance~* Other items are the same as conventional"

Trial Locations (1)

05505

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT06009224 - The Effect of ERAS on Pancreaticoduodenectomy (v2.0) | Biotech Hunter | Biotech Hunter